Experiment: 5UTV

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D CBCA(CO)NH	1.2 mM [U-13C; U-15N] HKU9 NSP3 C domain, 5 mM [U-98% 2H] DTT, .02 % sodium azide	97% H2O/3% D2O	.253 M	6	1 atm	298	Bruker AVANCE III 600
2	3D HNCO	1.2 mM [U-13C; U-15N] HKU9 NSP3 C domain, 5 mM [U-98% 2H] DTT, .02 % sodium azide	97% H2O/3% D2O	.253 M	6	1 atm	298	Bruker AVANCE III 600
3	3D HNCA	1.2 mM [U-13C; U-15N] HKU9 NSP3 C domain, 5 mM [U-98% 2H] DTT, .02 % sodium azide	97% H2O/3% D2O	.253 M	6	1 atm	298	Bruker AVANCE III 600
4	3D 1H-15N NOESY	1.2 mM [U-13C; U-15N] HKU9 NSP3 C domain, 5 mM [U-98% 2H] DTT, .02 % sodium azide	97% H2O/3% D2O	.253 M	6	1 atm	298	Bruker AVANCE III 850
5	3D 1H-13C NOESY aliphatic	1.2 mM [U-13C; U-15N] HKU9 NSP3 C domain, 5 mM [U-98% 2H] DTT, .02 % sodium azide	97% H2O/3% D2O	.253 M	6	1 atm	298	Bruker AVANCE III 850
7	3D 1H-13C NOESY aromatic	1.2 mM [U-13C; U-15N] HKU9 NSP3 C domain, 5 mM [U-98% 2H] DTT, .02 % sodium azide	97% H2O/3% D2O	.253 M	6	1 atm	298	Bruker AVANCE III 850
6	3D HBHA(CO)NH	1.2 mM [U-13C; U-15N] HKU9 NSP3 C domain, 5 mM [U-98% 2H] DTT, .02 % sodium azide	97% H2O/3% D2O	.253 M	6	1 atm	298	Bruker AVANCE III 700
9	3D 1H-15N TOCSY	637 uM [U-15N] HKU9 NSP3 C domain, 5 mM [U-98% 2H] DTT, .02 % sodium azide	97% H2O/3% D2O	.253 M	6	1 atm	298	Bruker AVANCE III 700
8	3D C(CO)NH	1.2 mM [U-13C; U-15N] HKU9 NSP3 C domain, 5 mM [U-98% 2H] DTT, .02 % sodium azide	97% H2O/3% D2O	.253 M	6	1 atm	298	Bruker AVANCE III 600
10	3D HCCH-COSY	1.2 mM [U-13C; U-15N] HKU9 NSP3 C domain, 5 mM [U-98% 2H] DTT, .02 % sodium azide	97% H2O/3% D2O	.253 M	6	1 atm	298	Bruker AVANCE III 600
11	3D HCCH-TOCSY	1.2 mM [U-13C; U-15N] HKU9 NSP3 C domain, 5 mM [U-98% 2H] DTT, .02 % sodium azide	97% H2O/3% D2O	.253 M	6	1 atm	298	Bruker AVANCE III 600
12	2D 1H-15N HSQC	1.2 mM [U-13C; U-15N] HKU9 NSP3 C domain, 5 mM [U-98% 2H] DTT, .02 % sodium azide	97% H2O/3% D2O	.253 M	6	1 atm	298	Bruker AVANCE III 700
14	2D 1H-13C HSQC aliphatic	1.2 mM [U-13C; U-15N] HKU9 NSP3 C domain, 5 mM [U-98% 2H] DTT, .02 % sodium azide	97% H2O/3% D2O	.253 M	6	1 atm	298	Bruker AVANCE III 700
15	2D 1H-13C HSQC aromatic	1.2 mM [U-13C; U-15N] HKU9 NSP3 C domain, 5 mM [U-98% 2H] DTT, .02 % sodium azide	97% H2O/3% D2O	.253 M	6	1 atm	298	Bruker AVANCE III 700
16	3D HNCACB	1.2 mM [U-13C; U-15N] HKU9 NSP3 C domain, 5 mM [U-98% 2H] DTT, .02 % sodium azide	97% H2O/3% D2O	.253 M	6	1 atm	298	Bruker AVANCE III 600
17	2D (HB)CB(CGCD)HD	1.2 mM [U-13C; U-15N] HKU9 NSP3 C domain, 5 mM [U-98% 2H] DTT, .02 % sodium azide	97% H2O/3% D2O	.253 M	6	1 atm	298	Bruker AVANCE III 600
18	2D (HB)CB(CGCDCE)HE	1.2 mM [U-13C; U-15N] HKU9 NSP3 C domain, 5 mM [U-98% 2H] DTT, .02 % sodium azide	97% H2O/3% D2O	.253 M	6	1 atm	298	Bruker AVANCE III 600

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	600
2	Bruker	AVANCE III	700
3	Bruker	AVANCE III	850

NMR Refinement
Method	Details	Software
energy minimization		Amber

NMR Ensemble Information
Conformer Selection Criteria	all calculated structures submitted
Conformers Calculated Total Number	20
Conformers Submitted Total Number	20
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure calculation	CYANA	2.0	Guntert, Mumenthaler and Wuthrich
3	peak picking	Unio '10	2.0.3	Serrano P, Pedrini B, Mohanty B, Geralt M, Herrmann T, Wuthrich K.
4	data analysis	CARA	1.9.0	Keller and Wuthrich
5	data analysis	Analysis	2.4	CCPN
6	collection	TopSpin	3.5	Bruker Biospin
7	refinement	Amber	AMBER03	Case, Darden, Cheatham III, Simmerling, Wang, Duke, Luo, ... and Kollman

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.